Schokker, S., van der Woude, S. O., van Kleef, J. J., van Zoen, D. J., van Oijen, M. G. H., Mearadji, B., . . . van Laarhoven, H. W. M. (2019). Phase I Dose Escalation Study with Expansion Cohort of the Addition of Nab-Paclitaxel to Capecitabine and Oxaliplatin (CapOx) as First-Line Treatment of Metastatic Esophagogastric Adenocarcinoma (ACTION Study). Cancers (Basel).
Chicago-tyylinen lähdeviittausSchokker, Sandor, et al. "Phase I Dose Escalation Study With Expansion Cohort of the Addition of Nab-Paclitaxel to Capecitabine and Oxaliplatin (CapOx) As First-Line Treatment of Metastatic Esophagogastric Adenocarcinoma (ACTION Study)." Cancers (Basel) 2019.
MLA-viiteSchokker, Sandor, et al. "Phase I Dose Escalation Study With Expansion Cohort of the Addition of Nab-Paclitaxel to Capecitabine and Oxaliplatin (CapOx) As First-Line Treatment of Metastatic Esophagogastric Adenocarcinoma (ACTION Study)." Cancers (Basel) 2019.